GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Boiron SA (XPAR:BOI) » Definitions » Total Equity

Boiron (XPAR:BOI) Total Equity : €391.5 Mil (As of Dec. 2023)


View and export this data going back to 1989. Start your Free Trial

What is Boiron Total Equity?

Boiron's total equity for the quarter that ended in Dec. 2023 was €391.5 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

Boiron Total Equity Historical Data

The historical data trend for Boiron's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Boiron Total Equity Chart

Boiron Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Total Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 505.46 509.17 531.77 557.35 391.50

Boiron Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 531.77 532.73 557.35 550.03 391.50

Boiron Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Boiron's Total Equity for the fiscal year that ended in Dec. 2023 is calculated as

Total Equity=Total Assets(Q: Dec. 2023 )-Total Liabilities(Q: Dec. 2023 )
=590.201-198.701
=391.5

Boiron's Total Equity for the quarter that ended in Dec. 2023 is calculated as

Total Equity=Total Assets(Q: Dec. 2023 )-Total Liabilities(Q: Dec. 2023 )
=590.201-198.701
=391.5

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Boiron Total Equity Related Terms

Thank you for viewing the detailed overview of Boiron's Total Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Boiron (XPAR:BOI) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Boiron SA (XPAR:BOI) » Definitions » Total Equity
Comparable Companies
XPAR:EAPI XPAR:AB XPAR:MLCOT XPAR:ALRPD XPAR:VETO XTER:MRK ZTS NSE:SUNPHARMA TSE:4502 LSE:HLN XTAE:TEVA XSWX:SDZ NBIX SZSE:000538 NSE:DIVISLAB BOM:532321 TSE:4507 HKSE:03692 VTRS TSE:4523
Traded in Other Exchanges
BOIRF:USA BON:Germany
Address
2, Avenue de l’Ouest Lyonnais No. 039, Messimy, FRA, 69510
Website
http://www.boiron.com
Boiron is a drug manufacturer that focuses on homeopathic products. The company's revenue is roughly split between its nonproprietary homeopathic medicines and products in its over-the-counter specialties category. Boiron's nonproprietary medicines are generic products that do not refer to any therapeutic indication, while the specialties category includes first-resort products provided in tablet form, are bottled to use as drops, syrups, or ointments. Geographical segments are France, Europe, North America, and other countries. It generates a majority of revenue from France. The company's products include Oscillococcinum, Stodal and Stodaline, Arnigel, Camilia, Sedatif PC, Coryzalia, Homeoptic, and Homeovox.

Boiron (XPAR:BOI) Headlines

No Headlines